JMC Investments Blog

  UnitedHealth Group (UNH) stock price has been cut roughly in half since November 2024.  It is currently going through some probes of it's business by the DOJ, but I view this as temporary noise for the company.   Below is a 13 year historical chart of UNH which shows the big price drop.  The black line (stock price) is now trading near the orange (Fair Value Ratio) line.  Warren Buffett and Michael Burry have recently bought shares of UNH recognizing it's much better valuation today.  The stock is not without risks given the DOJ probes that are ongoing, but it also offers tremendous upside value if the business can turn around.    UNH is one of the most popular stocks in top hedge funds and is a dividend growth stock.  It has a yield of 2.91% or $8.84/share annually.  Over the past 13 years, since December 2012, UNH has outperformed the S&P 500 with a $10,000 investment worth $68,000 as of August 27, 2025 versus the $56,201 fo...

This morning, August 25th, 2025, I purchased a small amount of shares of AMAT.  The Fastgraphs chart below shows that the stock is trading at near fair valuation.  Thus, we have a great semiconductor company trading at near fair valuation.  If the stock falls more, I will add to my share count and dollar cost average down.     Here is a screen shot of the past 13 year performance of AMAT versus the S&P500:  Notice on the 13-year performance screen shot that with dividends reinvested, a $10,000 investment in October 2012 would be worth $184,000 today versus $56,000 for the S&P500.  AMAT had a compound growth of 25.51% versus a respectable 14.51% on the S&P500.  AMAT's dividend growth rate and compound dividend growth rate were 13-14% which is solid.   I am always in search of great companies that are trading at a fair valuation that have a history of thrashing the S&P500.  They can be difficult to find bu...